Obesity and type 2 diabetes: can we find a compromised treatment solution?
Type 2 diabetes and obesity are two enormous epidemic diseases of the 21st century. Because obesity is a primary risk factor for type 2 diabetes development, patients with diabetes are frequently obese. This comorbidity makes it challenging for these patients to not only compensate diabetes...
Main Authors: | Gagik R. Galstyan, Ekaterina A. Shestakova, Igor A. Sklyanik |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2017-10-01
|
Series: | Сахарный диабет |
Subjects: | |
Online Access: | https://www.dia-endojournals.ru/jour/article/view/8726 |
Similar Items
-
The Therapeutic Potential of Anthocyanins: Current Approaches Based on Their Molecular Mechanism of Action
by: Bahare Salehi, et al.
Published: (2020-08-01) -
Bioactive properties of peptide fractions from Brazilian soy protein hydrolysates: In silico evaluation and experimental evidence
by: T.C. Farias, et al.
Published: (2023-12-01) -
Health effects of Conjugated Linoleic Acid
by: M Rahdari
Published: (2018-03-01) -
Chromatography analysis, in light of vitro antioxidant, antidiabetic, antiobesity, anti-inflammatory, antimicrobial, anticancer, and three-dimensional cancer spheroids’ formation blocking activities of Laurus nobilis aromatic oil from Palestine
by: Nidal Jaradat, et al.
Published: (2023-03-01) -
The efficacy and safety of setmelanotide in individuals with Bardet-Biedl syndrome or Alström syndrome: Phase 3 trial design
by: Robert M. Haws, et al.
Published: (2021-06-01)